| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12013-014-9889-4 |
| P698 | PubMed publication ID | 24659093 |
| P2093 | author name string | Jiong Yang | |
| Yibing Yang | |||
| Yuhui Lin | |||
| Chunxian Du | |||
| P2860 | cites work | Relative Roles of TGF-β and IGFBP-5 in Idiopathic Pulmonary Fibrosis | Q42031550 |
| Arsenic trioxide induces cardiac fibroblast apoptosis in vitro and in vivo by up-regulating TGF-β1 expression | Q42712179 | ||
| The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality | Q43834139 | ||
| TGF-β1 T869C polymorphism may affect susceptibility to idiopathic pulmonary fibrosis and disease severity. | Q44092484 | ||
| Effects of the angiotensin II type 1 receptor antagonist candesartan, compared with angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy | Q44637555 | ||
| Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12. | Q50232161 | ||
| TGF-β1 prevents simulated ischemia/reperfusion-induced cardiac fibroblast apoptosis by activation of both canonical and non-canonical signaling pathways | Q50236945 | ||
| Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis | Q50513904 | ||
| High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. | Q51778180 | ||
| Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung. | Q51801343 | ||
| Angiotensin II type 1 receptor antagonist attenuates lung fibrosis in hyperoxia-exposed newborn rats. | Q54343625 | ||
| A role for epidermal growth factor receptor in idiopathic pulmonary fibrosis onset | Q56984392 | ||
| TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT) | Q24813751 | ||
| Resveratrol represses YKL-40 expression in human glioma U87 cells | Q33732189 | ||
| Epithelium-specific deletion of TGF-β receptor type II protects mice from bleomycin-induced pulmonary fibrosis | Q34428905 | ||
| Differential expression and function of breast regression protein 39 (BRP-39) in murine models of subacute cigarette smoke exposure and allergic airway inflammation | Q34817644 | ||
| TGF-β1 regulates cell fate during epithelial-mesenchymal transition by upregulating survivin | Q37062041 | ||
| Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis | Q37273123 | ||
| TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids. | Q37414976 | ||
| Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis | Q37746072 | ||
| Extracellular matrix microenvironment contributes actively to pulmonary fibrosis | Q38123040 | ||
| YKL-40 is differentially expressed in human embryonic stem cells and in cell progeny of the three germ layers | Q39433175 | ||
| A selective near-infrared fluorescent probe for singlet oxygen in living cells | Q39533518 | ||
| Enteric glia inhibit intestinal epithelial cell proliferation partly through a TGF-beta1-dependent pathway | Q40327553 | ||
| P433 | issue | 1 | |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| P304 | page(s) | 251-257 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Cell Biochemistry and Biophysics | Q15755135 |
| P1476 | title | Expression and mechanism of BRP-39 in bleomycin-induced pulmonary fibrosis in rat. | |
| P478 | volume | 70 |
Search more.